SCHEMBL17757969

SCHEMBL17757969

CN(C)CCOc1cc2c(cc1Cl)NC1(CCN(C)CC1)C(NCc1cccc(Cl)c1)=N2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 3/20 0.37
▸ CDK9 P50750 3/20 0.37
▸ HRH4 Q9H3N8 2/20 0.35
▸ PDE5A O76074 1/20 0.33
▸ PDE1A P54750 1/20 0.33
▸ PDE1B Q01064 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ PDE7A Q13946 1/20 0.33
▸ PDE1C Q14123 1/20 0.33
▸ BRD4 O60885 6/20 0.33
▸ UTS2R Q9UKP6 1/20 0.33
▸ ADRA1B P35368 1/20 0.32
▸ NR4A2 P43354 1/20 0.32
▸ EIF2AK1 Q9BQI3 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32
▸ BRD2 P25440 1/20 0.32
▸ BRD3 Q15059 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17757971 0.97 CCNT1 (0.35) CCNT1CDK9HRH4PDE5APDE1A
SCHEMBL17757976 0.86 CCNT1 (0.37) CCNT1CDK9HRH4
SCHEMBL21982511 0.85 HRH4 (0.42) CCNT1CDK9HRH4EIF2AK1MAOB
SCHEMBL17757270 0.85 CCNT1 (0.37) CCNT1CDK9HRH4PDE5AEIF2AK1
SCHEMBL17757978 0.82 HRH4 (0.37) CCNT1CDK9HRH4
SCHEMBL17757147 0.82 CCNT1 (0.35) CCNT1CDK9PDE5APDE1APDE1B
SCHEMBL17757258 0.82 HRH4 (0.38) CCNT1CDK9HRH4BRD4BRD2
SCHEMBL17757253 0.82 HRH4 (0.38) CCNT1CDK9HRH4BRD4BRD2
SCHEMBL17757746 0.79 HRH4 (0.42) CCNT1CDK9HRH4ADRA1BMAOB
SCHEMBL17757007 0.78 CCNT1 (0.41) CCNT1CDK9HRH4ADRA1BMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2020-05-12 — — US disclosed
WO-2016075137-A1 SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2016-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647687-B2 Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death AIFM2, BAD, AIFM1 CCNT1 4252/4885CDK9 3993/4885HRH4 3044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback